Pfizer finds itself playing defense after shelving a promising Alzheimer’s treatment
By
Alicia Lasek
Jun 06, 2019
A large pharmaceutical company has come under fire, following reports that it failed to pursue a promising Alzheimer’s disease treatment.
Amgen pleads guilty in False Claims Act case
Dec 26, 2012
Amgen “marketed the spread” between the price practices pay for Aranesp and that patients pay as a means of driving sales — to the point of having speakers tell physicians that they could...